Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
Abroad (travel likely)RecruitingPHASE4
Conditions
Early-stage Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Kingston Health Sciences Centre, Kingston, Ontario, Canada
Lakeridge Health, Oshawa, Ontario, Canada
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
Study leads
Xinni Song, MD
Principal Investigator
Ottawa Hospital Research Institute